Performance of Two Hydrophobic IOLs

Launched by VIENNA INSTITUTE FOR RESEARCH IN OCULAR SURGERY · Dec 5, 2022

Keywords

ClinConnect Summary

This clinical trial is comparing two different types of hydrophobic intraocular lenses (IOLs), which are special lenses used to replace the cloudy lens in the eye during cataract surgery. The goal is to see how well each lens performs in the eye after surgery. If you are 21 years or older and have cataracts in both eyes, you may be eligible to participate. It’s important that your vision is still somewhat functional, and you should not have any other serious eye conditions that could interfere with the study results.

If you choose to join the trial, you will need to provide written consent before undergoing surgery. The trial is actively looking for participants, so if you meet the criteria, you could help contribute to valuable research that may improve cataract treatment for others. Please note that women who could be pregnant will need to take a pregnancy test before participating. Overall, this study is a great opportunity to help advance understanding of cataract surgery outcomes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age-related bilateral cataract
• • Age 21 or older
• • Visual acuity \> 0.05
• • Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant
• • Written informed consent prior to surgery
• Exclusion Criteria:
• • Relevant other ophthalmic diseases such as pseudoexfoliation syndrome (PEX), traumatic cataract, intraoperative Floppy Iris Syndrome (IFIS), or other co-morbidities that could affect capsular bag stability (e.g. Marfan syndrome)
• • Any ophthalmic comorbidity that may compromise visual function or create problems with measurements (e.g. macular degeneration, amblyopia, corneal scars, etc.)
• • Previous ocular surgery or trauma
• • Pregnancy (pregnancy test will be taken in women of reproductive age)

Trial Officials